T. Craig Meagher

Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome

Debraj GuhaThakurta, Nadeem A. Sheikh, Li-Qun Fan et al. · Clinical Cancer Research · 2015 · 132 citations · Full text

Life Sciences, Immunology, Oncology +17

Insulin-Like Growth Factor (IGF)-I/IGF-Binding Protein-3 Complex: Therapeutic Efficacy and Mechanism of Protection against Type 1 Diabetes

Wei Chen, Konstantin V. Salojin, Qing‐Sheng Mi et al. · Endocrinology · 2003 · 69 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

A BCMAxCD3 bispecific T cell–engaging antibody demonstrates robust antitumor efficacy similar to that of anti-BCMA CAR T cells

David J. DiLillo, Kara Olson, Katja Mohrs et al. · Blood Advances · 2021 · 56 citations · Full text

Life Sciences, Immunology, Oncology +17

Humanization of T cell–mediated immunity in mice

Michael J. Moore, Maggie Zhong, Johanna K. Hansen et al. · Science Immunology · 2021 · 20 citations

Life Sciences, Immunology, Molecular Genetics +16

REGN5458, a Bispecific BCMAxCD3 T Cell Engaging Antibody, Demonstrates Robust In Vitro and In Vivo Anti-Tumor Efficacy in Multiple Myeloma Models, Comparable to That of BCMA CAR T Cells

David J. DiLillo, Kara Olson, Katja Mohrs et al. · Blood · 2018 · 16 citations

Medicine, Immunology, Oncology +15